BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 18827856)

  • 1. The therapeutic effects of Rho-ROCK inhibitors on CNS disorders.
    Kubo T; Yamaguchi A; Iwata N; Yamashita T
    Ther Clin Risk Manag; 2008 Jun; 4(3):605-15. PubMed ID: 18827856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damage.
    Tan HB; Zhong YS; Cheng Y; Shen X
    Int J Ophthalmol; 2011; 4(6):652-7. PubMed ID: 22553739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho-ROCK inhibitors for the treatment of CNS injury.
    Kubo T; Yamashita T
    Recent Pat CNS Drug Discov; 2007 Nov; 2(3):173-9. PubMed ID: 18221230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axon growth inhibition by RhoA/ROCK in the central nervous system.
    Fujita Y; Yamashita T
    Front Neurosci; 2014; 8():338. PubMed ID: 25374504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho-ROCK inhibitors as emerging strategies to promote nerve regeneration.
    Kubo T; Hata K; Yamaguchi A; Yamashita T
    Curr Pharm Des; 2007; 13(24):2493-9. PubMed ID: 17692017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular mechanism and regulation of axon growth inhibition].
    Yamashita T
    Brain Nerve; 2007 Dec; 59(12):1347-53. PubMed ID: 18095484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal growth inhibitors and their receptors in spinal cord injury: from biology to clinical translation.
    Chambel SS; Cruz CD
    Neural Regen Res; 2023 Dec; 18(12):2573-2581. PubMed ID: 37449592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced neurite outgrowth of human model (NT2) neurons by small-molecule inhibitors of Rho/ROCK signaling.
    Roloff F; Scheiblich H; Dewitz C; Dempewolf S; Stern M; Bicker G
    PLoS One; 2015; 10(2):e0118536. PubMed ID: 25714396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
    Hunt D; Coffin RS; Anderson PN
    J Neurocytol; 2002 Feb; 31(2):93-120. PubMed ID: 12815233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury.
    Walmsley AR; Mir AK
    Curr Pharm Des; 2007; 13(24):2470-84. PubMed ID: 17692015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho kinase inhibition enhances axonal regeneration in the injured CNS.
    Fournier AE; Takizawa BT; Strittmatter SM
    J Neurosci; 2003 Feb; 23(4):1416-23. PubMed ID: 12598630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury.
    Kopp MA; Liebscher T; Niedeggen A; Laufer S; Brommer B; Jungehulsing GJ; Strittmatter SM; Dirnagl U; Schwab JM
    Cell Tissue Res; 2012 Jul; 349(1):119-32. PubMed ID: 22350947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
    Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z
    Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo.
    Lingor P; Teusch N; Schwarz K; Mueller R; Mack H; Bähr M; Mueller BK
    J Neurochem; 2007 Oct; 103(1):181-9. PubMed ID: 17608642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mevalonate Cascade and Small Rho GTPase in Spinal Cord Injury.
    Eftekharpour E; Nagakannan P; Iqbal MA; Chen QM
    Curr Mol Pharmacol; 2017; 10(2):141-151. PubMed ID: 26758952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the physiological role of CNS regeneration inhibitors.
    Baldwin KT; Giger RJ
    Front Mol Neurosci; 2015; 8():23. PubMed ID: 26113809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal responses to myelin are mediated by rho kinase.
    Alabed YZ; Grados-Munro E; Ferraro GB; Hsieh SH; Fournier AE
    J Neurochem; 2006 Mar; 96(6):1616-25. PubMed ID: 16441511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PirB is a novel potential therapeutic target for enhancing axonal regeneration and synaptic plasticity following CNS injury in mammals.
    Gou Z; Mi Y; Jiang F; Deng B; Yang J; Gou X
    J Drug Target; 2014 Jun; 22(5):365-71. PubMed ID: 24405091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Rho-associated kinase inhibition [correction of inhibiton] induces cofilin dephosphorylation and neurite outgrowth in PC-12 cells.
    Zhang Z; Ottens AK; Larner SF; Kobeissy FH; Williams ML; Hayes RL; Wang KK
    Cell Mol Biol Lett; 2006; 11(1):12-29. PubMed ID: 16847745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter inhibitors in CNS axon regeneration failure.
    Xie F; Zheng B
    Exp Neurol; 2008 Feb; 209(2):302-12. PubMed ID: 17706966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.